Xiaomeng Wang

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 23, 2023
Vemurafenib for BRAF V600-mutant Erdheim-Chester disease presenting with bilateral orbital involvement.

Xiaomeng Wang, Jie Cao, Weijiao Du

|Jul 29, 2021
Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.

Xiaomeng Wang, Jie Cao, Weijiao Du

Pageof 1

Frequent Collaborators